Applying of high-energy photon beams beside all advantages obstacled by photoneutrons that may cause extra dose to the patient that has not been considered in routine radiotherapy. The purpose of this study is calculation of neutron and gamma doses to a female undergoing a pelvic 18 MV irradiation. A simplified Linac head model as a sphere with 10 cm radius of tungsten and with the total spectrum of an isotropic neutron distribution was located inside a typical bunker. The female anthropomorphic phantom was irradiated with equal weighted four-field pelvic box (18MV). MCNPX (2.4.0) code was used to calculate of absorbed doses. The greatest effective dose, 1.04 mSv Gy-1, was calculated for the AP field while the lowest effective dose, 0.36 mSv Gy-1, was obtained for the RL field. The Percent risk of fatal second malignancy of neutron contamination following a 70 Gy x-ray treatment dose (with equal weights for each field, 17.5 Gy) is 0.152 %, including 0.056 % for the AP field, 0.033 % for the PA field, 0.031 % for the RL field and 0.032 % for the LL field. If this dose delivered only with the AP field, the risk would be 0.224 %, which is 32 % higher than that is in case of 4-field irradiation. Our present analysis shows that this simplified model can be used to estimating of photoneutron doses.
INTRODUCTION

Background
In radiotherapy, for deep-seated tumors, e.g. in the pelvic region, higher photon energies such as 18 MV are widely used because of their lower integral dose and better therapeutic gain 1 . The main obstacle is the production of neutrons through interactions of photon (>8 MV) with high atomic number (Z) materials of accelerator structure and the treatment room, as well as within the patient body 2, 3 . Furthermore, gamma rays from neutron capture reactions are also generated in both the linac head and the patient body. The dose from these contaminant neutrons should be considered in patient extra-target calculation due to their high relative biological effectiveness values (W R ≤ 5).
As far as we know photoneutron doses, its related effective dose and the risk of developing a fatal secondary malignancy due to contaminant neutrons from female-pelvic irradiation has not investigated yet.
Considering the limitations and complications associated with neutron measurement (an accuracy better than 10% can rarely be achieved) especially in medical fields 3 , the MC approach 4 has shown more flexibility and capabilities in calculating dosimetric quantities required in medical dosimetry. In the present study, using the simplified model linac's head validated for photoneutrons 5 , the mean absorbed dose in an organ, D T , the equivalent dose in an organ, H T, and the effective dose, E, from the neutron contaminant have been calculated by Monte Carlo method for a female-pelvis irradiation with 18 MV x-ray beam. Doses from capture gamma rays and neutrons were calculated, separately.
Objectives
The purpose of this study is the calculation of neutron and gamma doses to chosen organs from18 MV X-ray female pelvic irradiation and the risk of developing a fatal secondary malignancy due to contaminant neutrons.
Material and methods
In the current study, the general-purpose MCNPX (2.4.0) Monte Carlo code was used to simulate radiation transport 4 . The neutron doses calculated by the f6 tally (a track-length estimator based on the use of the restricted or total stopping power of the particle). The ENDF/B and RMCCS cross section data files were used. Each simulation was performed with 10 9 histories as a compromise of relative errors of results and run time.
The total spectrum of an isotropic neutron distribution from the accelerator head can be obtained by considering the relative contribution of two mechanisms, evaporation contribution and direct process, as follow: Where E n is the neutron energy (in MeV), T is the nuclear temperature of the neutrons from a particular nucleus (in MeV), E max is the maximum energy of the photons (in MeV) and the constant of 7.34 denote the average binding energy of emitted neutrons from the tungsten (in MeV) (6, 7) . By considering T= 0.5 MeV and E max =18 MeV, the photoneutron spectrum can be expressed as:
Linac head can be modeled as a 10 cm sphere of tungsten and the neutron source was considered as an isotropic point-like source, its spectrum given by Equation 2, located at the center of it (5, (7) (8) (9) . A variable cone aperture was defined in the wall of tungsten sphere to provide various field size dimensions. Full bunker walls (2.26 g cm -3 concrete) and door 1.7 cm lead sandwiched between two 20 cm thickness paraffin layers) were simulated.
The anthropomorphic phantom was modeled on the basis of quadratic and planar equations according to the ORNL report (10) . Specifications for the elemental compositions of lung (0.296 g cm -3 ), skeletal (1.40 g cm -3 ) and soft tissue (1.04 g cm -3 ) were obtained from ICRU-44 report (11) . The pelvis was irradiated with four fields (10 ×10 cm 2 ) of antero-posterior (AP, 0°), posteroanterior (PA, 180°), right lateral (RL, 270°) and left lateral (LL, 90°) in SSD (source to surface distance)=100cm. The related doses were calculated for each of these four field with delivering of 17.5 Gy (from 25 fractions of 70 MU; 1 MU= 1 cGy ) to the isocenter. Furthermore, in a separate simulation it was supposed that the total dose of 70 Gy (4 ×17.5 Gy) delivered by a single field (AP) in order to compare of our data with other's data. As an aid to clinical applications, the neutron source strength (Q) value for Varian-2300 CD model (18 MV), 0.95 × 10 12 neutron per Gy reported by Followill et al. (2003) , was used to convert the MCNPX output from deposited energy per incident neutron to deposited energy per 1Gy x-ray dose at the isocenter 12 .
Neutrons were transported without any lower energy-cutoff while gamma captured photons were transported down to the energy of 0.01 MeV. The total equivalent dose, H T, in each organ, T, across the total interval energy was estimated using the following equation:
Where E n is the neutron energy of the i th neutron energy interval, D T (E n ) is the absorbed dose of organ T for i th neutron energy interval, H T (n) is the equivalent dose of organ T from neutrons and H T (γ) is the equivalent dose of organ T from secondary photons 13 . The appropriate radiation weighting factors, W R (E n ), for neutrons recommended by ICRP-60 report (1991) 13 were derived from the following equation:
The effective dose was calculated by multiplying the calculated total equivalent doses to organs by the organ-weighting factor, W T , as recommended by ICRP-60 report (1991) 13 . 14 .
RESULTS AND DISCUSSION
The calculated neutrons have a peak of 0.5 and 0.3 MeV before and after transmitted the linac head, respectively. The average energy of photoneutrons before and after crossing the head for 10, 15, 18, 20 MeV were 0.9, 1.08, 1.25, 1.31 MeV and 0.46, 0.48, 0.51, 0.53 MeV respectively. These energy ranges of neutrons have the greatest values of radiation weighting factors 15 . The average photoneutron energies after filtration through the linac head reported were from 0.5 to 0.8 MeV for 10-18 MVx-ray beams 2 . The mean value of ~0.5 MeV was repoeted by Howell et al. (2006) 16 . Photoneutrons with energies of 1-2 MeV and 0.2 to 2 MeV were reported by NCRP-79 report before and after the filtration of linac's head, respectively 6 . Readers is referred to our pervious paper to the details of validation about our proposed simplified model 5 .
The organs inside the primary beam receive greater neutron doses (table 1) . For example, greater neutron doses received by the The photon contribution to the total equivalent dose for some deeper organs has considerable value compared to the neutron component (table 2) . For example, the contribution of the photon dose reached up to 70 % for stomach in the RL field and 75 % in the PA field. Therefore, it may be crucial to calculate the gamma capture dose (from neutron interaction) and the neutron dose separately because of different radiation weighting factors (W R = 1 for photon, W R ≤ 5 for neutron). Therefore, if the gamma capture rays not taken into account separately it may result in underestimating equivalent dose especially for deep-seated organs. The greatest effective dose, 1.04 mSv Gy -1 , was calculated for the AP field and the Ovaries have the maximum contribution (0.54 mSv Gy 16 , respectively. The effective photoneutron dose following 70 Gy (only for the AP field) was about 0.07 Sv. Delivering this dose with equal weighting factor from the four field (with equal weights for each field, 17.5 Gy) reduces the effective dose to 0.05 Sv.
The fatal secondary malignancy risk has the minimum value for the RL field (0.0017 % Gy -1 ) and the maximum for the AP field (0.0032 % Gy -1 ), see table 4. The maximum contribution of fatalities belongs to the bladder wall in the AP field, 0.011 % Gy -1 . The percent risk of fatal secondary malignancy of neutron contamination following a 70 Gy x-ray treatment dose (with equal weights for each field, 17.5 Gy) is 0.152 %, which included 0.056 % for the AP field, 0.033 % for the PA field, 0.031 % for the RL field and 0.032 % for the LL field. If this dose delivered only with the AP field the risk would be 0.224 %, which is 32 % higher than that is in form of box irradiation.
CONCLUSION
The calculated percent risk of fatal secondary malignancy of neutron contamination following a prescriped dose of 70 Gy x-ray during a typical female pelvic irradiation was 0.152 %. We successfully built a Monte Carlo simulation model using a simplified Linac's head to calculate photoneutron dose parameters that has not been considered in routine radiotherapy.
